DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 2347762
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2347762
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Aug 18, 2026 | Astrazeneca Ab | BYDUREON | exenatide synthetic |
➤ Try a Free Trial | Aug 18, 2026 | Astrazeneca Ab | BYDUREON PEN | exenatide synthetic |
➤ Try a Free Trial | Aug 18, 2026 | Astrazeneca Ab | BYDUREON BCISE | exenatide |
➤ Try a Free Trial | Aug 18, 2026 | Astrazeneca Ab | FARXIGA | dapagliflozin |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |